Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis

IMPORTANCE: Patients with chronic kidney disease and type 2 diabetes have a higher risk of developing pneumonia as well as an increased risk of severe COVID-19–associated adverse events and mortality. Therefore, the anti-inflammatory effects of mineralocorticoid receptor antagonists via blockade of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitt, Bertram, Agarwal, Rajiv, Anker, Stefan D., Ruilope, Luis M., Rossing, Peter, Ahlers, Christiane, Brinker, Meike, Joseph, Amer, Lambelet, Marc, Lawatscheck, Robert, Filippatos, Gerasimos S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606845/
https://www.ncbi.nlm.nih.gov/pubmed/36287567
http://dx.doi.org/10.1001/jamanetworkopen.2022.36123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606845/
https://www.ncbi.nlm.nih.gov/pubmed/36287567
http://dx.doi.org/10.1001/jamanetworkopen.2022.36123

Ejemplares similares